Table 2.
Distribution of demographic and clinical markers of CF disease for PE recurrence among 125 children
| Recurrence no | |||
|---|---|---|---|
| First PE (n = 114) | Second PE (n = 89) | Third PE (n = 28) | |
| Age, years | 11.3 (2.8) | 13.1 (2.9) | 14.1 (2.2) |
| Sex, female | 55 (48.2) | 41 (46.1) | 11 (39.3) |
| BMI, Z score | − 0.59 (0.88) | − 0.62 (0.87) | − 0.83 (0.9) |
| Pancreatic insufficiency | 72 (63.2) | 59 (66.3) | 23 (82.1) |
| CFTR genotype | |||
| F508del/other | 47 (41.2) | 37 (41.6) | 11 (39.3) |
| F508del/F508del | 30 (26.3) | 27 (30.3) | 10 (35.7) |
| Other/other | 37 (32.5) | 25 (28.1) | 7 (25) |
| Pseudomonas aeruginosa, free | 68 (59.6) | 50 (56.2) | 18 (64.3) |
| FEV1, % predicted | 99.4 (17.3) | 96.3 (18.1) | 93.8 (16.0) |
| FEV1, Z score | − 0.03 (1.46) | − 0.29 (1.52) | − 0.51 (1.35) |
| LCI | 10.3 (2.99) | 10.6 (3.44) | 10.8 (2.64) |
| LCI, Z scorea | 5.51 (8.44) | 5.64 (8.84) | 7.19 (8.64) |
Values are presented as mean (standard deviation) or count (percentage)
aMedian (IQR)